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Background: Three different gene clusters code for the muscle-specific miRNAs miR-206, miR-1 and miR-133a/b.
The two miR-1/133a clusters generate identical mature miR-1 and miR-133a miRNAs in heart and skeletal muscle,
while the cognate miR-206/133b cluster is exclusively expressed in skeletal muscle. Since sequences of the miRNAs
miR-133a and miR-133b are almost identical, it seems likely that they share potential targets. Similarly, miR-1 and
miR-206 are structurally related and contain identical seed sequences important for miRNA-target recognition. In
the past, different functions of these miRNAs were suggested for development, function and regeneration of
skeletal muscle using different in vivo and in vitro models; however, mutants lacking the complete miR-206/133b
cluster, which generates a single pri-miRNA constituting a functional unit, have not been analyzed.
Methods: We generated miR-206/133b knock-out mice and analyzed these mice morphologically; at the
transcriptome and proteome level to elucidate the contribution of this miRNA cluster for skeletal muscle development,
differentiation, regeneration in vivo; and by systematic analysis. In addition, we studied the consequences of a genetic
loss of miR-206/133b for expression of Pax7 and satellite cell differentiation in vitro.
Results: Deletion of the miR-206/133b cluster did not reveal any obvious essential function of the miRNA-cluster for
development and differentiation of skeletal muscle. Careful examination of skeletal muscles of miR-206/133b mutants
revealed no structural alterations or molecular changes at the transcriptome and proteome level. In contrast to previous
studies, deletion of the miR-206/133b cluster did not impair regeneration of skeletal muscle in mdx mice. Likewise,
differentiation of miR-206/133b deficient satellite cells in vitro was unaffected and no change in Pax7 protein
concentration was apparent.
Conclusions: We conclude that the miR-206/133b cluster is dispensable for development, function and regeneration
of skeletal muscle, probably due to overlapping functions of the related miR-1/133a clusters, which are strongly
expressed in skeletal muscle. We reason that the miR-206/133b cluster alone is not an essential regulator of skeletal
muscle regeneration, although more subtle functions might exist that are not apparent under laboratory conditions.
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miRNAs regulate protein expression at the post-
transcriptional level by decreasing transcript abundance
or inhibiting protein translation. The miRNAs miR-1,
miR-206 and miR-133a/b are specifically expressed in
striated muscle. The mouse genome contains two miR-1/
133a gene clusters located on chromosome 2 and 18,
giving rise to identical mature miR-1 and miR-133a miR-
NAs while the structurally related miR-206/133b cluster is
located on mouse chromosome 1. The mature miR-133b
differs in only one nucleotide from miR-133a and the
primary sequence of miR-206 is highly related to miR-1.
Importantly, miR-1 and miR-206 do not differ in the seed
sequence that is assumed to determine target specificity of
miRNAs [1]. Deletion of both miR-1/133a clusters, which
are expressed in heart and all skeletal muscles, results in
early embryonic lethality due to defects in heart develop-
ment caused by the failure to restrict myocardin expression
and concomitant upregulation of smooth muscle genes [2].
Deletion of both miR-1 copies leads to cardiac defects with
partially penetrant neonatal lethality [3] but did not cause a
major skeletal muscle phenotype, which was attributed to
the remaining expression of miR-206 in skeletal muscle.
Deletion of both miR-133a copies affects cardiomyocyte
proliferation and heart physiology [4] and results in a cen-
tronuclear skeletal myopathy and a shift of muscle fiber
identity from glycolytic to oxidative muscle fibers in the
soleus muscle [5].
The miR-206/133b cluster is not expressed in the heart,
but its expression is confined to developing skeletal
muscle. In adult muscles miR-206/133b are preferentially
found in slow myofibers. Expression of miR-206/133b is
controlled by a network of myogenic regulatory genes
[6,7], including MyoD, which binds to the miR-206/133b
locus in C2C12 cells [8]. The miR-206/133b locus not only
encodes the miRNAs miR-206 and miR-133b, but also the
long non-coding RNA linc-MD1, which is expressed dur-
ing muscle development similar to miR-206 and miR-
133b and assumed to act as a competing endogenous
RNA or miRNA decoy [9]. Genomic deletion of miR-206
did not cause an obvious clinical phenotype in mice,
although it was determined that miR-206 is required for
re-innervation of muscle tissue in mice with mutant Sod1
[10]. It was proposed that miR-1/206 repress Hdac4 [11],
which in turn might regulate genes involved in controlling
muscle-derived signals that enhance synapse formation
under pathological conditions [10]. More recently, miR-
206 was claimed to act as a modifier of muscular dys-
trophy [12]. Deletion of miR-206 in the mdx mouse model
of Duchenne muscular dystrophy [13,14] led to increased
lethality in compound mutants and accumulation of
degenerated muscle fibers. Surprisingly, no defects in
muscle innervation were observed after the loss of miR-
206, although muscle fibers are continuously lost andreplaced in mdx mice. The dramatic enhancement of
muscle dystrophy in miR-206/mdx compound mutants
was attributed to impaired differentiation of myofibers
due to the up-regulation of Pax7, which contains identical
binding sites for miR-206 and miR-1 in its 3′ untranslated
region (UTR) [12]. The presence of miR-206 target sites
in Pax7 did also motivate other researchers to investigate
a regulation of Pax7 by miR-206, revealing that overex-
pression or knock-down of miR-206 can affect Pax7 levels
and thereby muscle differentiation in vitro [15,16].
Here, we analyzed mice with a targeted deletion of the
miR-206/133b cluster. miR-206/133b are processed from
a common precursor and thus might be regarded as a
functional unit similar to the miR-1/133a clusters [2].
Concomitant loss of miR-206 and miR-133b neither leads
to an obvious clinical phenotype or causes detectable mo-
lecular changes in skeletal muscles nor impairs muscle
regeneration in the MDX mouse model of muscular dys-
trophy. Surprisingly, lack of miR-206/133b and the miR-
133 decoy, contained in the third exon of linc-MD1, did
not have obvious effects on satellite cell proliferation and
differentiation. Our findings differ from a previous analysis
of miR-206 mutants, which might suggest that other prod-
ucts processed from the primary miR-206/133b transcript
balance effects of miR-206 in vivo.
Methods
Ethics statement
Animal maintenance and animal experiments were in
accordance with German animal protection laws and were
approved by the local governmental animal protection
committee (Regierungspraesidium Darmstadt, Federal State
of Hessen).
Deletion of miR-206/133b
The miR-206/133b coding region was deleted from the
mouse genome using a vector containing genomic se-
quences flanking the miRNA miR-206/133b gene and a
PGK-neomycin selection cassette. The short arm (2.3 kb)
used for recombination encompassed the miR-206 5′
flanking region from TTAGGCATATAAAGTTTGCAC-
GACC to GATATAAAGAAGCATGTGGCCTGGG). The
long arm of the targeting vector consisted of a 5.9 kb NcoI
fragment directly downstream of miR-133b. A DTA selec-
tion cassette was used for negative selection against non-
homologous insertion of the vector into the genome.
Homologous recombination in mouse embryonic stem
(ES) cells was ascertained by Southern blot analysis using
a SphI digest and a 453 bp 5′ probe amplified by the oli-
gonucleotides (TAAGTCCTGATGCTTCTCAATACCC;
GTTGATAAAGAAACTGTGTGTTACG), resulting in an
8.4-kb WT and an 11.8-kb knock-out signal. Although the
inserted β-galactosidase coding (lacZ) cassette contained
an IRES sequence, no β-galactosidase was expressed from
Boettger et al. Skeletal Muscle 2014, 4:23 Page 3 of 13
http://www.skeletalmusclejournal.com/content/4/1/23the engineered locus. Genotyping of mdx mice followed
the protocol described by Shin et al. [17]. Primary se-
quences of mature miRNAs were derived from mirBase20
(MIMAT0000239, MIMAT0000123, MIMAT0000769 and
MIMAT0000145) [18].
RNAse protection assay and northern blot
Total RNA was isolated from M. soleus of PBS perfused ani-
mals using the TRIZOL method (Invitrogen, Thermo Fisher
Scientific, Darmstadt, Germany). The RNase protection
assay was performed using the mirVana Probe construc-
tion Kit (Ambion, Thermo Fisher Scientific, Darmstadt,
Germany; Cat#1550) using oligos (miR-206: TGGAATG-
TAAGGAAGTGTGTGG, miR-145: GTCCAGTTTTCC-
CAGGAATCCCTTTTTTTT) together with the mirVana
miRNA Detection Kit (Ambion#1552) following the man-
ufacturer’s instructions. A polyT at the control oligo was
added to allow size resolution of the control oligo. The
sequence CCTGTCTC was added to the 3′ end of the
oligos to allow binding of the Ambion T7-Promoter
Primer. Amersham α-32P UTP (GE Healthcare, Freiburg,
Germany; PB20383, 800 Ci/mmol) was used for labeling.
Probes were purified using a 15% Invitrogen TBE-Urea
Gel (EC68855BOX), the gel was exposed to a Kodak X-ray
film, labeled probes were excised und eluted 30 min in
elution buffer. 5 μg of total RNA isolated from WT,
heterozygous or KO-muscle or yeast-RNA (Roche,
Mannheim, Germany), respectively was hybridized at
42°C overnight with approximately 104 cpm of probe in
hybridization buffer in a total volume of 20 μl. Samples
were analyzed using 15% TBE-Urea gels after RNase A/
T1 digestion. Signals were detected using Kodak X-Ray
film. Northern blot analysis was performed as previ-
ously described [19]. Antisense oligonucleotides specific
for miR-206 (CCACACACTTCCTTACATTCCA), miR-1
(ATACATACTTCTTTACATTCCA) and U6 (ATATG
GAACGCTTCACGAATT) were used.
Microarray analysis, quantitative reverse transcription
PCR and small RNA sequencing
RNA quality was analyzed with the Agilent Bioanalyzer
and the RNA 6000 Nano Kit (Agilent Technologies, Santa
Clara, CA). For RNA expression analysis, the Affymetrix
GeneChip MouseGenome 430 2.0 Array was used,
employing the one-cycle target labeling protocol. Data
were analyzed using the Affymetrix expression console
and the RMA algorithm. Microarray data have been
submitted to Arrayexpress (Acc#E-MTAB-2439). TaqMan
MicroRNA Expression Assays and the Applied Biosystems
StepOnePlus system were used to quantify miR-206 and
miR-1 expression. The RT reaction was done using the
miR-206 and the U6 specific primer with the Taqman
MicroRNA Reverse Transcription Kit (#4366596). qPCR
assays were performed with three independent sampleseach with Taqman Universal PCR Master Mix (#4324018),
FAM labeled miR-206 or miR-1 assay (#000510; #002222)
and VIC labeled U6 assay (#001973) for normalization.
Relative expression was calculated using the ΔΔCt
method. RNA isolated from a pool of M. soleus of five
male C57Bl6 mice was sequenced using IonTorrent se-
quencing and analyzed as described [20]. Data were
submitted to the NCBI’s Gene Expression Omnibus
(Acc#GSE63342).Whole-mount in situ hybridization
For whole mount in-situ hybridization, a myogenin cDNA
corresponding to 307 to 1393 bp of ENSMUST00000027730
was used to synthesize a DIG-labeled antisense probe by
T7-RNA-polymerase. E10.5 embryos were isolated and ge-
notyped after mating of heterozygous parents.Fiber type determination, histology
For histological analysis, muscle tissue was perfused in
situ with 4% PFA, dissected, washed in PBS, dehydrated
and embedded in paraffin, followed by preparation of
10 μm sections, deparaffinization and hydration in dis-
tilled water. Von Kossa staining was performed by incu-
bating slides with 1% silver nitrate solution and exposed
to light for 30 min. Slides were washed two times for
3 min in H2O and incubated in 5% sodium thiosulfate
solution for 5 min. Thereafter, slides were washed two
times in H2O, followed by counterstaining for 7 min in
0.1% EosinG (Merck, Darmstadt, Germany) with 0.05%
acetic acid. Slides were dehydrated and mounted using
Entellan. For Sirius red staining, slides were stained in
Weigerts Iron-Hematoxylin solution (Sigma, Munich,
Germany; Cat#HT1079) for 8 min, dipped twice in dis-
tilled water and stained one hour in 0.1% Direct Red 80
(Sigma#365548)/saturated picric acid. Subsequently,
slides were washed using 0.5% acetic acid, dipped in dis-
tilled water, dehydrated and mounted using Entellan.
For determination and quantification of fiber types in
the muscle tissue, tissue was perfused in situ with 4%
PFA, isolated and incubated in 15% and 30% sucrose/
PBS for 2 hours and overnight, respectively. Tissue was
frozen on dry ice and cryotome-sectioned. Sections were
mounted on Superfrost slides. Tissue was dried and sub-
sequently treated with 4% PFA/0.1% sodium desoxycho-
late/0.02% NP-40 for 5 min, washed 3 times with PBS
for 5 min, blocked in 2% FCS, 0.5% NP-40/PBS for 1 h
and then incubated with monoclonal anti-myosin (skel-
etal, slow; Sigma, M8421) in 2% FCS/0.5% NP-40/PBS
overnight at 4°C. Slides were washed three times with
PBS for 5 min and then incubated with biotinylated sec-
ondary antibody (Vector Labs, Burlingame, CA; BA-
1400) for 2 h at RT and further processed according to
the Vectastain Elite ABC Kit.
Boettger et al. Skeletal Muscle 2014, 4:23 Page 4 of 13
http://www.skeletalmusclejournal.com/content/4/1/23Satellite cell isolation and culture
Satellite cells were isolated from the hind leg muscles of
approximately 20 to 25-week-old wildtype and miR-206/
133b knock-out animals by using the skeletal muscle dis-
sociation kit (Miltenyi Biotech, Bergisch Gladbach,
Germany, 130-098-305) and enriched by the satellite cell
isolation Kit, mouse (Miltenyi Biotech, 130-104-268) ac-
cording to the manufacturer’s instructions. Isolated cells
were plated on gelatin-coated μclear 96-well plates (Sig-
ma#M0562). Satellite cells were grown in proliferation
medium (40% DMEM, 40% Ham F-10; 20% FCS; Pen/
Strep; 2.5 ng/ml human FGF-2, Miltenyi Biotech#130-
093-840) for 3 days, followed by switch to differentiation
medium (DMEM, 2% horse serum, and Pen/Strep). Cells
were incubated for 5 min in fixative (4% PFA/PBS, 0.1%
sodium desoxycholate, 0.2% NP-40), washed 3 times in
PBS, blocked in carrier (PBS, 5% BSA, 0.5% NP-40) for
1 h and then incubated with MF 20 supernatant in car-
rier (1:100, DSHB, Iowa City, Iowa). Secondary anti-
body was goat anti-mouse IgG1 Alexa 488 (1:2000, Life
technologies).
Quantitative proteomics
Soleus muscle was dissected from adult 13C6Lys-labeled
(SILAC) WT and from nonlabeled WT and miR-206/
133b mutant littermates. Protein extracts were processed
and mass spectrometry was performed as described pre-
viously [19,21]. Briefly, 30 μg protein extracts of soleus
muscle of labeled and the respective unlabeled muscle
were combined, size-fractionated into 10 fractions using
SDS-PAGE, and the proteins were digested in-gel using
the endoproteinase LysC. After digestion peptides were
eluted from gel-fractions using an acetonitrile gradient.
Peptides were desalted prior to LC-MS/MS analysis and
loaded onto a 15 cm in-house packed column (75 μm
ID, C18 Beads 3 μm diameter, Dr. Maisch, Germany)
and eluted by an linear increase of buffer B within a bin-
ary buffer system: A) 0.5% acetic acid and B) 80% ACN,
0.5% acetic acid. The flow-rate was set to 200 nL/min
and gradient time to 150 min. The Agilent 1200 nano-
flow HPLC system was coupled to an LQT-Orbitrap XL
(Thermo Scientific) via an electrospray ionization source
(Thermo Fisher Scientific). The mass spectrometer was
operated in the data-dependent mode to automatically
measure full MS scans and MS/MS spectra. In detail,
survey scans were measured after accumulation of 1E6
ions at a resolution of 60,000 and subsequently isolation
and fragmentation (CID, 35% norm. collision energy, tar-
get value: 5,000) of the top five intense peaks was
performed in the linear ion trap. Peptides were identified
by correlation of acquired MS/MS spectra against the
mouse IPI (ftp://ftp.ebi.ac.uk/pub/databases/IPI) using
MaxQuant software [22]. A FDR cutoff of 1% was set on
the protein and peptide level. Two mis-cleavages wereallowed. Amidomethylation at cysteine residues was set as
fixed modification, while oxidation on methione residues and
acetylation at the N-term of proteins were defined as variable
modifications. Quantification of proteins was performed by
MaxQuant software. Only peptides with a minimal length of
six amino acids and at least two ratio counts for SILAC pairs
were used for quantification. Using SILAC as an internal
standard, ratios miR-206/133b KO/13C6Lys-WT and
13C6Lys-
WT/WT were obtained and were used for calculation of the
direct KO/WT ratios for relative protein abundance.
Western blot
For western-blot analysis of embryonic tissue, the trunk
of E10.5 embryos posterior of the otic placode was
used. A total of 10 μg of protein extract were loaded
onto a 9% SDS-PAGE and blotted onto nitrocellulose
membranes. The following antibodies were used: anti-
Pax7 (supernatant of DSHB#P3U1), anti-pan-actin
(1:1000, CST, Frankfurt, Germany; Cat#4968), anti-
GAPDH (1:1000, CST; Cat#2118), secondary anti-
bodies were anti-mouse-HRP (1:1000, eBioscience,
Affymetrix, Frankfurt Germany, Cat#18-8816-31) and
anti-rabbit-HRP (1:5000, Pierce, Thermo Fisher Scien-
tific, Darmstadt, Germany, Cat#1858415).
Statistics
Data are reported as mean ± SEM. Differences between
groups were tested for statistical significance using the
unpaired Student’s. For microarray experiments the me-
dian of groups was used and statistical analysis using an
unpaired t-test was performed using DNAStar Arraystar
11 software (annotation na33). The Benjamini-Hochberg
FDR correction [23] was used to control the multiple
hypothesis testing in case of the microarray experiments.
Results
Deletion of the miR-206/133b cluster does not alter
skeletal muscle morphology
To analyze the function of the miR-206/133b miRNA
cluster we deleted the coding region of the miR-206/
133b gene on mouse chromosome 1 by homologous re-
combination (Figure 1A, B). The targeting strategy also
removed the last exon of the ncRNA linc-MD1 including
the putative miR-133a/b binding site in linc-MD1 [9],
which is identical to the miR-133b* sequence. Neither
the putative miR-135 binding sites in the second exon of
linc-MD1, nor the described distal or proximal regula-
tory elements [9], identified by myogenin or myoD
ChIP-seq approaches in C2C12 myocytes [8,24], were af-
fected by the targeting strategy. Targeted deletion of the
miR-206/133b coding region was validated by southern
blot analysis (Figure 1C). Viable knock-out mice were
obtained by breeding of heterozygous animals. Deletion
of the miR-206/133b cluster did not impair embryonic
Figure 1 Generation of miR-206/133b knock-out mice. The miRNAs miR-206, miR-1 and 133a/b are encoded in three clusters on mouse
chromosome 1, 2 and 18. The primary sequence (A) of mature miR-1/133a encoded on chromosome 2 and 18 is identical, miR-206 differs in four
bases from miR-1, and miR-133b differs in one base from miR-133a (red). The seed sequence, which is instrumental for target binding of miRNAs,
is identical between the corresponding miRNAs (blue). Schematic representation of the miR-206/133b genomic region (B) with deleted parts
indicated (red). Southern blot analysis (C) of genomic DNA isolated from wildtype (WT), heterozygous, and homozygous mutant animals proves
deletion of the miR-206/133b locus. An SphI digest of genomic DNA and a probe hybridizing 5′ prime of the targeting vector were used to monitor
targeting of the miR-206/133b locus by homologous recombination. RNase protection assay (D) and northern blot (E) analysis demonstrates the loss
of miR-206 in the soleus muscle of knock-out animals. Expression of miR-1 is not changed in soleus muscle of miR-206/133b knock-out mice.
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mdxY/+ mice). To exclude a function of miR-206/133b in
early development that might be compensated during later
stages we analyzed the spatial distribution of myogenin
transcripts at the embryonic stage E10.5. No differences in
somite morphology and myogenin expression wereTable 1 Normal Mendelian distribution of offspring at the
time of weaning
Genotype N % observed Expected
miR-206/133b+/+ mdxy/+ 29 13.0% 12.5%
miR-206/133b+/+ mdxy/- 25 11.2% 12.5%
miR-206/133b+/− mdxy/+ 57 25.6% 25.0%
miR-206/133b+/− mdxy/- 41 18.4% 25.0%
miR-206/133b−/− mdxy/+ (a) 35 15.7% 12.5%
miR-206/133b−/− mdxy/- (b) 36 16.1% 12.5%
Total 223 100.0% 100.0%
Deletion of the miR-206/133b cluster does not lead to abnormalities in the
Mendelian distribution of mutant animals (a) at the time of weaning. Additional
mdx mutation of the dystrophin gene does not lead to further lethality in double
mutant animals (b). Distribution of male offspring after mating of male miR-206/
133b+/− mdxy/+ or miR-206/133b+/− mdx+/+ to female miR-206/133b+/−
mdx+/− is presented.detected (Figure 2). Development of body weights and
survival rate of miR-206/133b knock-out mice was indis-
tinguishable from WT animals. RNase protection analysis
as well as northern blot analysis using RNA isolated from
hind limb muscle confirmed the absence of miR-206 in
homozygous mutant animals (Figure 1D, E). Due to the
presence of miR-133a in skeletal muscles, which differs by
only one nucleotide from miR-133b, it was not possible to
demonstrate the absence of mature miR-133b in homozy-
gous mutant animals.
The miR-206/133b cluster is predominantly expressed
in muscles with a high content of oxidative type I myofi-
bers such as the soleus muscle and less abundant in mus-
cles with only few oxidative fibers (Figure 3A). Analysis of
published small RNA sequencing results [25] reveals that
miR-206 is much less abundant in skeletal muscle than
the related miR-1 (GSM539875; 20124 miR-206 versus
745064 miR-1 tags per million miRNA tags). Small RNA
sequencing of mouse soleus muscle revealed that even in
the muscle with highest expression of miR-206 miR-1 is by
far the most abundant miRNA (GSE63342; 30812 miR-206
versus 281944 miR-1 tags per million miRNA tags). The
expression of miR-1 was not significantly altered after loss of
Figure 3 Expression of miR-206 is confined to skeletal muscle. Express
PCR (qRT-PCR) in tissues isolated from wildtype (WT) (open bars), miR-206/
detected in skeletal muscle of the WT mice. miR-206 is not detected in mu
the knock-out tissue and specificity of the Taqman assay. miR-206 was at the
miR-206 was strongly expressed in the soleus muscle, which has a high conte
was detected in the diaphragm, as well as in other skeletal muscles. In mdx m
Increased miR-206 expression was detected in the diaphragm and other skele
muscles and appeared unchanged in the soleus muscle of miR-206/133b kno
in the expression of miR-1. Samples were isolated from ≥3 different animals e
Figure 2 Deletion of miR-206/133b does not impair myogenesis
during somite development. miR-206/133b knock-out animals are
born with the expected Mendelian distribution (see text), whole
mount in situ hybridization indicates normal myogenin expression in
wildtype (WT; A, C) and knock-out embryos (KO; B, D) at embryonic
day 10.5. Sections (C, D) are at the level of the forelimbs.
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ination of M. soleus did not reveal obvious morphological
alterations. We detected no changes in fiber size, fiber type
distribution (Figure 4) or localization of myofiber nuclei.
Similar results were obtained for other skeletal muscles
(data not shown).
miR-206/133b mutant skeletal muscles do not show
significant molecular abnormalities
To investigate whether the loss of expression of miR-206/
133b leads to changes of gene expression levels we per-
formed Affymetrix GeneChip analysis using RNA isolated
from M. soleus and mouse genome 430 2.0 arrays (n = 9
WT, n = 8 KO). Only few and subtle changes were de-
tected by this type of analysis (Figure 5). The strongly and
significantly downregulated probe set 1446563_at detects
RNA transcribed from the miR-206/133b locus with the
probes binding between the both miRNAs but not within
the known linc-MD1 exons. This finding additionally con-
firms the successful knock-out strategy and suggests that
this probe set detects the common miR-206/133b precur-
sor RNA. The only gene that was significantly (2.5-fold)
upregulated after false discovery rate correction [23] was
IL-17a, which is located downstream of the miR-206/133bion of miR-206 (A) is detected by quantitative reverse transcription
133b knock-out and mdxy/- (gray bars) mice. Expression of miR-206 is
scles isolated from knock-out mice, confirming the loss of miR-206 in
qRT-PCR detection limit in heart and brain of WT mice. In WT mice,
nt of type 1/oxidative skeletal muscle fibers. A lower amount of miR-206
ice, the expression of miR-206 was not increased in soleus muscle.
tal muscles. Expression of miR-1 (B) was also analyzed in the respective
ck-out mice (black bar). Mdx mutation did not cause significant changes
ach, and qRT-PCR was performed in triplicate for each of the samples.
Figure 4 No alterations in fiber type identity and fibers size in miR-206/133b knock-out mice. Sections of the soleus muscle isolated from
adult wildtype (WT) (A) and mutant mice (B) were stained for markers of slow myofibers. No changes in fiber size of slow and fast muscle fibers
were detected (C; n ≥8 per group, 30 fibers per animals). The ratio of slow/fast muscle fibers was unchanged in the soleus muscle of knock-out
compared to WT mice (D). The scale bar in A corresponds to 100 μm in A and B.
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manipulation of the neighboring miRNA locus. No other
gene was significantly deregulated in soleus muscle. In
particular, we did not observe up-regulation of predicted
miR-206 or miR-133b target genes.
Since microRNAs regulate expression on the transcript
or protein level [26,27], we performed an unbiased
SILAC based proteomics screen to detect potential
miRNA targets that are regulated at the translational
level. Proteins were isolated from M. soleus of WT and
miR-206/133b mutant mice and combined with proteins
obtained from soleus muscles of 13C6Lys-labled mice,
which serve as a reference for relative quantification. In
total, we identified 1,500 proteins and 805 were quanti-
fied in two independent experiments. SILAC ratios of
WT/13C6-Lys-WT and in knock-out/
13C6-Lys-WT were
used to calculate the direct KO/WT ratios for each of the
experiments [19,21]. In accordance with our transcrip-
tome analysis, only few changes in protein concentrations
between knock-out and WT soleus muscle were observed
(Figure 6A). Although we quantified 94 potential miR-206
targets that displayed a good score according to the mi-
Randa [28] based microRNA.org target prediction database
(August 2010 release) [29], none of the potential target pro-
tein was upregulated more than 1.5 fold in the knock-out
tissue. Likewise, none of the 57 proteins found in ourSILAC data set that were predicted as miR-133b targets ac-
cording to the microRNA.org database were upregulated.
Although no alterations in skeletal muscle development
of miR-206/133b mutants were apparent, we investigated
the potential regulatory interaction between miR-206 and
Pax7 in somites of E10.5 embryos. No changes in Pax7 pro-
tein expression were detected in mutant compared to WT
embryos indicating that miR-206 is not required to sup-
press expression of Pax7 in somites (Figure 6B, C), probably
due to the presence of miR-1, which shows a similar ex-
pression pattern as miR-206 during skeletal muscle devel-
opment but is more widely expressed compared to miR-
206 in adult muscles. In fact, the seed sequences of miR-1
and miR-206 are identical, which predicts a comparable re-
pression of Pax7 by either miR-206 or miR-1 (Figure 6D)
according to target algorithms like miRanda [28]. Taken to-
gether, neither transcriptome nor proteome analysis re-
vealed significant changes in gene expression between WT
and KO mice, which is in line with the lack of a muscle spe-
cific phenotype in miR-206/133b knock-out mice.
Loss of the miR-206/133 cluster does not affect skeletal
muscle regeneration in Duchenne muscular dystrophy
model mice
Previously, miR-206 has been implicated in muscle fiber
stability and regeneration of skeletal muscles, although
Figure 5 No transcriptional changes in the soleus muscle of
miR-206/133b knock-out (KO) mice. The scatter blot of the
median of the log2 signals of wildtype (WT) (n = 9) versus KO
(n = 8) indicates only few genes with expression changes more
than twofold (green lines). The probe set 1446563_at detects RNA
originating from the genome between miR-206 and miR-133b
most likely the pri-miRNA of these miRNAs. The weak signal for this
probe set in WT samples is reduced to the detection limit in the
KO samples. Only a few of the detected changes in gene expres-
sion are significant after statistical analysis using Student’s t-test.
None of these changes could be verified by quantitative reverse
transcription PCR (qRT-PCR) or analysis of protein expression. After
false discovery rate correction by the Benjamini-Hochberg
algorithm, only one gene directly downstream of the manipulated
genomic locus significantly changed expression.
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eration and differentiation of skeletal muscle [12]. To
analyze the potential function of miR-206/133b miRNAs
and their targets in maintenance and regeneration of
muscle fibers we generated miR-206/133b−/−//mdxY/-
compound mutant mice. Mdx mice carry a point muta-
tion in the dystrophin gene on the X-chromosome leading
to constant damage and loss of muscle fibers, which is
compensated by increased regeneration [30]. miR-206/
133b−/−/mdx mutant mice were born at the expected
Mendelian ratio (Table 1) and developed normally, which
is in contrast to the previously described miR-206−/−/mdx
mutant mice [12]. Body weight development (Figure 7A,
B) and survival (Figure 7C) of compound mutant animals
was indistinguishable from mdx mice. Regeneration of
skeletal muscles in mdx mice leads to increased expres-
sion of the miR-206/133b cluster in muscles with a low
content of type I muscle fibers that express only low levels
of miR-206/133b under normal conditions (Figure 3A,[12]). In contrast we observed a moderate, not significant
reduction of miR-1 in some mdx muscles (Figure 3B), pos-
sibly related to the emergence of other non-muscle cell
types in the dystrophic muscles. Hence, it seems possible
that such muscle might be affected by inactivation of miR-
206/133b in conditions of constant regeneration. Loss of
dystrophin expression results in the release of muscle cre-
atine kinase (MCK) from muscle fibers into the blood,
which serves as an indicator of muscle injury or muscle
degenerative processes [31]. To access the degree of
muscle damage in miR-206/133b−/−/mdx mutant mice we
determined MCK activity in serum of adult mice. Only
very low MCK activity was detected in WT and miR-206/
133b mice, which did not differ significantly between WT
(297 ± 85 U/l, n = 6) and mutants (152 ± 62 U/l, n = 11).
Importantly, we observed much higher MCK activities
in mdx mice (8590 ± 1507 U/l, n = 6), which were not
increased any further in miR-206/133b/mdx mutants
(8024 ± 2464 U/l, n = 6; Figure 8) indicating that com-
pound mutants do not suffer from increased muscle fiber
damage compared to mdx mice. Next, we performed a
comprehensive histological analysis of different muscles
of the hind limb, as well as of the diaphragm from WT,
miR-206/133b−/−, mdxY/- and miR-206/133b−/−//mdxY/-
mice. Trichrome- and Sirius Red-, and von Kossa staining
were used to determine myofiber organization, fibrosis,
and intramuscular calcifications often present in mdx
mice (Figure 9). No differences were found between WT
and miR-206/133b skeletal muscle based on Trichrome-
(not shown), von Kossa or Sirius red staining including
absence of fibrosis and calcifications. Mutation of dys-
trophin caused the typical signs of muscle dystrophy,
namely massive thickening of the diaphragm, enhanced
fibrosis and patches of calcified tissue within the diaphragm
and the M. quadriceps (Figure 9). No calcified fibers were
observed in the soleus muscle. Deletion of miR-206/133b
in mdx mice did not cause a more severe phenotype in the
soleus, quadriceps or diaphragm muscles compared to
single mutant mdx mice. Together these data indicate that
loss of miR-206/133b cluster does not increase muscle
damage in mdx mice or compromise skeletal muscle
regeneration in constantly renewing muscle tissue.
To further analyze a possible function of the miR-206/
133b cluster in the differentiation of muscle stem cells, we
isolated muscle satellite cells from WT and miR-206/133b
mutant mice. Loss of the miR-206/133b cluster did not
impair the ability of muscle stem cells to differentiate to
myotubes in vitro (Figure 10A). We did not observe re-
duced differentiation as accessed by the number of MF20
positive cells nor changes in the fusion of myocytes as
accessed by the number of myotubes with more than one
nucleus (Figure 10B). Moreover, we found that the lack
of miR-206/133b did not increase the concentration of the
potential miR-206 and miR-1 target Pax7 in differentiating
Figure 6 miR-206/133b does not modulate abundance of PAX7 in E10.5 embryos. SILAC-based screening of changes in protein abundance
based on two independent pairs of miR-206/133b knock-out / wildtype (WT) samples revealed few changes that were greater than 1.5 fold up or
down in miR-206/133b knock-out versus WT M. soleus (A). Not one of the proteins expected to be potentially upregulated was a predicted target
of miR-206 or miR-133b (microRNA.org). In accordance with transcriptome data, no change in protein abundance could be confirmed in western
blot analysis. Loss of miR-206/133b does not change the abundance of PAX7 protein in the trunk of E10.5 embryos (B, C). Analysis of the 3′
untranslated region (UTR) of Pax7 using miRanda indicates identical binding sites for miR-206 and miR-1. Differences in the primary sequence of
miR-206 and miR-1 do not lead to substantial changes in the predicted miRNA-Pax7 UTR interaction (D).
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ation (Figure 10C).
Discussion
Physiological properties of skeletal muscle cells including
specification, differentiation, function and regeneration
are controlled by an extensive network of regulatory mole-
cules [32]. Many key genes have been identified that are
essential for specification and differentiation of muscle
precursor cells during development. Commitment of
muscle cells is controlled by a core program of myogenicregulatory factors of the MyoD family, which also control
transcription of the miR-1/206/133 miRNA clusters [6,33]
resulting in a prominent expression of these miRNAs in
muscle cells. Yet, important differences in the expression
pattern of miR-1/206/133 miRNA clusters exist: the
miR-1/133a clusters are expressed in heart and all skeletal
muscles, while expression of miR-206/133b becomes re-
stricted to a subset of oxidative muscle fibers by hitherto
unknown molecular mechanisms. Since the two miR-1/
133a clusters display virtually identical expression pat-
terns, partially overlapping or redundant functions of
Figure 7 No difference in body weight and survival of miR-206/133b and mdx mutant mice. (A) The body weight of male animals is not
different at 6 weeks of age (n ≥11/group); however, at later ages (B), the mdx mutation leads to an increase in body weight that is not further
modified by mutation of the miRNA cluster (wildtype (WT): miR-206/133b+/+, knock-out (KO): miR-206/133b−/−; MDX: mdxY/-; n ≥5/group).
(C) Survival of miR-206/133b mutants is not impaired. The mdx mutation does not affect survival of miR-206/133b knock-out mice.
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cluster shows a more restricted expression, which might
argue for a distinct function of this cluster albeit muscle cells
expressing miR-206/133b also transcribe miR-1/133a. In
addition, the primary sequence of miR-206 differs from
miR-1 while miR-133b is very similar to miR-133a. However,
the seed sequences of miR-206 and miR-1 important forFigure 8 Loss of miR-206/133b does not change serum creatine
kinase activity. Creatine kinase activity in the serum in miR-206/133b
mice knock-out mice is not altered. The mdx mutation leads to strong
increase of creatine kinase activity. No differences were observed in
mdx versus miR-206/133b KO / MDX mice (n ≥6/group).target recognition [1] are identical, indicating only limited
differences in the target specificity of miR-206 and miR-1.
The miR-206/133b locus also directs expression of the long
non-coding RNA linc-MD1, which was postulated to act as
a competing endogenous RNA or miRNA decoy [9] adding
a further potential function to the miR-206/133b locus.
We have generated a miR-206/133b knock-out allele by
deletion of the genomic region spanning from miR-206 to
miR-133b and resulting in removal of the third exon of
the linc-MD1 that might act as a miR-133 sponge. Sur-
prisingly, homozygous deletion of the miR-206/133b locus
did not cause an apparent phenotype in adult mice. No
changes in the morphology and distribution of muscle
fiber types were apparent and the transcriptional and pro-
teomics signatures of miR-206/133b mutant muscles were
virtually unchanged, ruling out that miR-206 and/or 133b
alone play an essential role in muscle physiology. These
observations are consistent with to observations made in
miR-206 knock-out mice, which also show no obvious
phenotype under baseline conditions [12]. Apparently, the
concomitant loss of miR-206, miR-133b and the potential
miR-133 sponge in linc-MD1 is compatible with normal
muscle development and functions, which might be ex-
plained by expression of the miR-1/133a clusters in type I
myofibers compensating for deletion of miR-206/133b.
Theoretically, the inactivation of miR-133b might also be
counteracted by the loss of the miR-133 sponge function,
Figure 9 miR-206/133b mutation does not modulate muscle loss or regeneration in Mdx mice. No histological changes are observed in
diaphragm or M. quadriceps after loss of miR-206/133b. Mutation of the mouse dystrophin gene (MDX) leads to increased muscle mass, calcifications
(von Kossa staining) and increased fibrosis (red signal in Sirius red staining). Additional loss of miR-206/133b does not lead to changes of the mdx
phenotype. Sections obtained from 12 weeks old animals are shown, similar results are obtained using tissue from 6-week- and 9-month-old mice.
The scale bar corresponds to 200 μm in the upper three rows and to 50 μm in the lower two rows.
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peting RNAs has been questioned making this explanation
less likely [34].
We found a more widespread and abundant expres-
sion of the miR-206/133b cluster in regenerating mus-
cles, which confirms previous findings [12]. It seems
possible that the expression of miR-206 in regenerating
muscle reflects a specific function of the miR-206/133b
in the regenerative response. However, it is important to
point out that miR-206/133b is broadly expressed during
development in immature muscle cells. Hence, it is diffi-
cult to exclude that the increased expression of miR-
206/133b during skeletal muscle regeneration simply
mirrors the immature state of newly formed myofibers
that have not yet terminated expression of the miR-
206/133b cluster in the majority of mature type II fibers
[35]. The lack of a more severe phenotype in miR-206/
133b−/−//mdxY/- compound mutants compared to mdxY/-
mice clearly argues against an important role of the
miR-206/133b cluster for skeletal muscle regeneration.
Moreover, we did not see an increase in lethality or an
increase in serum creatine kinase levels in compoundmutant mice, which also excludes an important role of the
miR-206/133b cluster in restricting myofiber damage.
miR-206 has been claimed to suppress Pax7 expression
thereby regulating muscle stem cell renewal and differentiation.
The normal expression of Pax7 in isolated miR-206/133b
mutant satellite cells and the normal differentiation of mu-
tant satellite cells to myotubes in vitro do not argue for an
important role of miR-206 in Pax7 expression. These
results are in contrast to previous publications mostly
relying on the inhibition of miR-206 by anti-miRs [16],
overexpression of miR-206 [15,36], or by correlation of
expression profiles [37,38]. It seems possible that previous
anti-miR approaches were biased by off-target effects or
affected expression of miR-1, which can also suppress
Pax7. Generation of skeletal muscle specific miR-1/
miR133a//miR-206/133b triple mutants will probably
solve this controversy in the future. We do not have a
convincing explanation for the attenuation of Pax7 down-
regulation in differentiating miR-206-deficient satellite
cells reported by Liu et al. [12]. The same authors also
described that miR-206/mdx mutant mice suffer from in-
creased muscle degeneration, impaired regeneration and
Figure 10 No differences in differentiation of muscle
progenitor cells in vitro. Proliferating muscle stem cells isolated
from hind limb muscles of wildtype (WT) and miR-206/133b knock-out
mice (KO) were induced to differentiate and stained after 3 or 5 days
in differentiation medium (DM) for expression of myosin (green: MF20
staining, blue: nuclear staining; the scale bar corresponds to 50 μm).
No differences in cell morphology or differences in the expression of
myosin were detected between WT and mutant cells (A). Formation of
fused myotubes from differentiating myoblasts was not impaired by
the loss of the miR-206/133b cluster (B). Pax7 expression in
differentiating myogenic progenitor cells was detected by western
blot. No differences in Pax7 expression were detected after loss of
miR-206/133b (C).
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133b mutants. In principle, it is feasible that the con-
comitant loss of mir-206 and miR-133b in our model
accounts for these differences, which would strengthen
the notion that the miR-206/133b cluster acts as a func-
tional unit targeting similar biological processes some-
times in parallel and sometimes in opposing directions
[2,11]. Alternatively, subtle differences in the genetic
background and/or strain-depended differences in the
expression of miR-1/133a compensating for the loss of
miR-206/133b might differentially affect the course ofmuscular dystrophy in miR-206/133b−/−//mdxy/- and
miR-206−/−//mdxy/- compound mutants.
Conclusion
Taken together, our results question a major role of
the miR-206/133b cluster in development, function and
regeneration of skeletal muscle in mouse and argue for
overlapping functions of the miR-206/133b and miR-1/
133a gene clusters during myogenesis. Our findings are
in line with the hypothesis that individual miRNAs often
fine-tune biological processes and play modulatory roles.
Further genetic studies targeting the miR-1/133a together
with the miR-206/133b gene clusters specifically in skele-
tal muscle will probably reveal the prevalent physiological
function of miR-1/206/133 in mammals.
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